Uncategorized FDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant Infections 21 Mar 202021 Mar 2020 --Three Clinical Sites to Enroll Patients with Recurrent and Complicated Urinary Tract Infections-- GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response…